Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
Read Article
News
2024
2023
Archive
Search news articles
September 7, 2017
CRINETICS PHARMACEUTICALS AWARDED TWO SBIR GRANTS TO DEVELOP NEW THERAPEUTICS FOR CONGENITAL HYPERINSULINISM AND CUSHING’S DISEASE
August 29, 2017
RARECYTE COMPLETES $30M PRIVATE FINANCING FOR COMMERCIAL EXPANSION OF RARE CELL DETECTION TECHNOLOGY FOR LIQUID BIOPSIES
August 11, 2017
VIVEVE ANNOUNCES SECOND QUARTER 2017 FINANCIAL RESULTS AND STRATEGIC PARTNERSHIP WITH INCONTROL MEDICAL, LLC
August 11, 2017
VIVEVE ANNOUNCES SECOND QUARTER 2017 FINANCIAL RESULTS AND STRATEGIC PARTNERSHIP WITH INCONTROL MEDICAL, LLC
August 8, 2017
APREA THERAPEUTICS ANNOUNCES FIRST PATIENT ENROLLED IN PHASE IB/II CLINICAL STUDY OF APR-246 FOR THE TREATMENT OF PLATINUM-RESISTANT HIGH-GRADE SEROUS OVARIAN CANCER
August 8, 2017
APREA THERAPEUTICS ANNOUNCES FIRST PATIENT ENROLLED IN PHASE IB/II CLINICAL STUDY OF APR-246 FOR THE TREATMENT OF PLATINUM-RESISTANT HIGH-GRADE SEROUS OVARIAN CANCER
August 4, 2017
KINESTRAL TECHNOLOGIES RECEIVES THE 2017 NORTH AMERICAN SMART GLASS NEW PRODUCT INNOVATION AWARD
August 1, 2017
HOMOLOGY MEDICINES ANNOUNCES $83.5 MILLION SERIES B FINANCING TO ADVANCE LEAD DEVELOPMENT CANDIDATE AND AMENDR™ IN VIVO GENE EDITING TECHNOLOGY
July 13, 2017
CRINETICS PHARMACEUTICALS AWARDED $2.8 MILLION SBIR GRANT TO SUPPORT DEVELOPMENT OF ACROMEGALY DRUG CANDIDATE CRN00808
July 12, 2017
PORTAL INSTRUMENTS APPOINTS WENDY DWYER AS CHIEF BUSINESS OFFICER
« Previous Page
1
2
3
4
5
6
…
8
Next Page »